Recently, New Horizon Health released a hundred day report on Chang ColoClear's listing in Hong Kong. During this period, 6000 people/share were sold, and 2000 people/share were inspected and exceeded. The market price was HK $3000. ColorClear is a trump brand product of genetic testing sold in Southeast Asia by Prenetics through Technical Transferer.
For ColorClear, the Southeast Asia region where it is developing is more densely populated, and the proportion of tested population is lower, only 5.7%. Therefore, it can be predicted that this product will bring high growth to Prenetics. According to the forecast of Frost&Sullivan, the sales revenue of ColorClear will increase rapidly at an annual rate of 111% from 2022 to 2025.
0 nhận xét:
Đăng nhận xét